Mainstream

Fennec Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $8.75M beats by $0.57M

Fennec Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $8.75M beats by $0.57M

Post Contentfenc, frx:caRead More

You might also be interested in reading ScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025.

May 13, 2025
In Mainstream